What to do, now that big pharma and psychiatry have thrown empiricism under the bus by Wyatt, W. Joseph
Marshall University
Marshall Digital Scholar
Psychology Faculty Research Psychology
Spring 5-2010
What to do, now that big pharma and psychiatry
have thrown empiricism under the bus
W. Joseph Wyatt
Marshall University, Wyatt@marshall.edu
Follow this and additional works at: http://mds.marshall.edu/psychology_faculty
Part of the Other Psychology Commons, and the Theory and Philosophy Commons
This Article is brought to you for free and open access by the Psychology at Marshall Digital Scholar. It has been accepted for inclusion in Psychology
Faculty Research by an authorized administrator of Marshall Digital Scholar. For more information, please contact zhangj@marshall.edu.
Recommended Citation
Wyatt, W. J. (2010, May). What to do, now that big pharma and psychiatry have thrown empiricism under the bus. [Presentation
slides]. Association for Behavior Analysis International 36th Annual Convention, San Antonio, TX.
What To Do, Now That Big Pharma 
and Psychiatry Have Thrown 
Empiricism Under The Bus
W. Joseph Wyatt, Ph.D.
Marshall University
Huntington, WV
Wyatt@Marshall .edu
Presented at the Association for Behavior Analysis International
San Antonio, May 2010
For a more complete review, see:
www.behaviorandsocialissues.org
Behavior and Social Issues
Vol 15,2 (special issue) and vol. 16,2.
or
Wyatt, W. J. (2009). Behavior analysis in the 
era of medicalization: The State of the 
science and recommendations for 
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Q: Why is this important?
A:  Answers:
 The 35-yr. emphasis on biological causation has 
rendered medications as the treatment of choice.
 Behavioral treatment may be cast aside, as a 
result.
 When people believe their problems are 
biologically caused, they feel less 
responsibility…
 …and have less hope for improvement.
Phelan (2002)
Trends in Neuroscience
 Bio causation is related to prejudice, fear 
and desire for distance…
Haslam, Sayce, Davies (2006)
ACTA Psychiatrica Scandinavica
A growing problem:
Increasing numbers of clients show 
up for therapy already convinced 
that their difficulties are caused by 
their biology:
• Their Genes
• A chemical imbalance
• exposure to a toxin
• etc.
Organized psychology has 
pushed the bio model
Headline: “Public recognizes depression as 
illness”
“Ten years ago…only 38% viewed depression 
as a serious medical illness…Today nearly three 
quarters (believe that)…We’ve come a long way.”
David L. Shern, Ph.D., 
The National Psychologist (2007).  16, 15
…and an implicit message these days is, 
you’d better take your meds…
Or
…don’t let this happen to you…
Caution:
Some disorders are biologically determined, or partly 
biologically determined.
Autism
Tumor-related
Toxin-related
Endocrine & metabolic related
Genetic-related (Down’s syndrome, for example)
Others
Q: Why has the public’s 
perception changed?
Q: And what does that mean for 
our behavioral treatment efforts?
“Psychiatry’s Anxious Years”
NY Times (Nelson, 1982)
 Residency drop from 1970-1980, 11% to 
5% of medical school grads.
– Relatively low pay
– Family practice emphasis
– Psychoanalytic confusion
– Fringe Treatments & loss of esteem
– “Intruder” professions
Psychiatry’s response to this 
crisis?
Strategy conferences held.
Solution:
Become more medical, and
Attack the intruders
Organized psychiatry’s attacks on 
non-medical “intruders” quickly 
became vicious.
Some examples follow:
Hospital & Community Psychiatry (Bursten, 
1981):
“Medicalization” of disorders is useful “to 
rally the troops…to thwart the 
attackers…Economics demands that we be 
medical…we use the term to rout the enemy 
within.”
Another
 Paul Fink, President-elect of Am. 
Psychiatric Assn. 1988:
“(Non-psychiatrists) don’t have the training to 
make the initial evaluation and 
diagnosis…(and) are not trained to 
understand the nuances of the mind…”
Conclusion:
 Organized psychiatry’s 35-year emphasis 
upon biological causation has been 
motivated, in part, by non-science based 
factors including:
– Protection of its turf from “outsider” 
professionals
– Re-establishing its esteem
Psychiatry finds a willing 
partner.
Big Pharma
Pharmaceutical Company 
Financial Interests
 Question: How to achieve symbiosis with 
organized psychiatry?
 Answer: Promote the biological causation 
model of disorders.
The marketing of psychotropic 
medications:  Successful?
2009
Top ten revenue producing drugs included:
–Zyprexa
–Risperdal
–Effexor
$12.1 billion in sales in the U.S.
Health and Life (2010)
Direct-to-Consumer
advertising:
Legalized in 1995 
Does direct-to-consumer 
advertising influence physicians’ 
Rx’ing?
Journal of the American Medical Association
Kravitz, Epstein, Feldman, Franz, Azari, Wilkes, Hinton & Franks, 2005
Subjects & Method:
152 family doctors were visited unannounced 298 times by 
actors posing as patients.  
The “patients” pretended to have symptoms of either major 
depressive disorder or adjustment disorder with depressed 
mood.
At some visits the “patients” said, “I saw 
an ad for Paxil on TV.  Doctor, do you 
think Paxil could help me?”
At other visits the “patients” said that they 
had seen an ad for “an anti-depressant” on 
TV, but didn’t specifically mention Paxil.
At still other visits the “patients” made no 
reference to medication.
Results
Rx of Paxil when the “patients” exhibited 
major depressive disorder*:
 Mention of “Paxil” 27.4% 
 Mention of “a drug” 2.0%
 No mention of drugs 4.2% 
*Similar percentages for adjustment disorder
Another conclusion:
 The pharmaceutical industry’s marketing 
efforts (including direct-to-consumer 
advertising) have increased dramatically 
since 1995.
 Sales of medications, including 
psychotropic medications, have escalated at 
the same time.
Marriage
Psychiatry Pharmaceutial 
Industry
Cementing this marriage 
together is:
Biological causation theory
Reinforcers of this marriage:
Money and power
The Drug Industry
Strikes Paydirt.
 September 2007
 U.S. Children diagnosed with bi-polar 
disorder:
1994 20,000
2003 800,000
Children’s use of anti-psychotic meds shows 
corresponding increase.
Olsen, et. al, Archives of Gen Psychiatry
Medical schools at Stanford, Mount 
Sinai, Yale, U. Penn and others 
offer classes to teach medical 
students “how to effectively spar 
with the drug reps” by asking 
aggressive questions.
Dr. Ethan Halm, 
Mt. Sinai School of Medicine, 
AP, November 2007
The Pharmaceutical Industry:
From 
Hypocrates 
to 
Husksterism
Example:
Pharmaceutical companies 
routinely claim a 
Serotonin-depression connection.
…but, what do the experts say?
“…I never saw any convincing 
evidence that any psychiatric 
disorder, including depression, 
results from deficiency of brain 
serotonin.”
David Burns, winner of the A. E. Bennett 
Award given by the Society for Biological 
Psychiatry for his research on serotonin 
metabolism.
“…no abnormality of serotonin 
in depression has ever been 
demonstrated.”
David Healy, former secretary of the 
British Association for 
Psychopharmacology, 2004.
“We have hunted for big simple 
neurochemical solutions for 
psychiatric disorders and have 
not found them.”
Kenneth Kendler, co-editor-in-chief of 
Psychological Medicine, 2005.
“Advertisements that claim 
depression is caused by a 
chemical imbalance and that 
anti-depressants correct it, are 
false and should be banned.”
Jonathan Leo and Jeffrey Lacasse, 
Public Library of Science 
Medicine, 2007
“The chemical imbalance theory 
(of depression) is a ‘useful 
metaphor’ but shouldn’t be used 
when talking to patients.”
Wayne Goodman, Chair
Psychopharmacologic 
Advisory Committee
U.S. FDA
Does all of that 
matter?
Inquiring minds 
want to know.
Sooo, 
Here are some examples of Big 
Pharma’s advertising.
“Celexa helps to restore the 
brain’s chemical imbalance.”
Forest Pharmaceuticals, 2005
“LEXAPRO appears to work by 
increasing the available supply of 
serotonin…In people with depression 
and anxiety, there is an imbalance of 
serotonin…”
Forest Pharmaceuticals, 2005
“When you’re clinically 
depressed…the level of 
serotonin …may drop…The 
medicine doctors now 
prescribe most is Prozac.”
Eli Lilly, 1998
“…depression may be related 
to an imbalance of natural 
chemicals…Zoloft works to 
correct this…”
Pfizer, 2004
“(Pristiq) is thought to work by 
changing the (brain’s) levels of 
norepinephrine and serotonin.”
Wyeth Pharmaceuticles, April, 2010
Conclusion:
Pharmaceutical Industry 
advertising is not to be 
believed.
Q: Will the FDA save us?
A: Not likely
 “FDA Science and Mission at Risk”
– Inadequate staffing
– Poor retention
– Out-of-date technology
– General lack of resources
Report of the FDA’s Science Board, 2007
FDA:
 FDA found “serious problems” at drug test 
sites 348 times, 2000-2005. Only 26 
investigators were disqualified from 
conducting further clinical studies.
Daniel Levinson
HHS Inspector General, 2007 
Q: How well do psychotropic 
medications work?
A: Some studies are revealing.
Torfanil & Paxil: Common 
Antidepressants.
Sources: 6 studies; 718 patients took one of 
these meds for 6 to 11 weeks.
Findings: 
 Meds were no better than placebo, for mild to 
moderate depression (Hamilton Depression Scale 
scores below 23 (out of 50).
 Slightly better than placebo for severe depression.
Fournier, et. al (2010) 
JAMA
Another Review
Sources: 85 studies of 12 anti-depressants.
Findings:
37 of 38 that produced positive results 
were published
3 of 36 with negative results were 
published 
11 with negative or questionable results 
were written as if the drug had worked.
Turner, et al., NEJM, 2008
Another Review
 38 Studies of anti-depressants (Zoloft, Paxil, 
Serzone, Celexa, Effexor, etc.), 1987 to 
1999.
 Dependent measure: The 50-point Hamilton 
Depression Scale.
 Results:  
– Mean improvement, drug groups = 10 points
– Mean improvement, controls        =  8 points
Kirsch, et. al, (2002)
Prevention & Treatment
Another review:
Sources: 19 studies of top-selling 
anti-depressants.
Primary result: Placebo accounted 
for 75% of improvement.
Kirsch & Saperstein, 1998
Prevention & Treatment
CDC Study, 2005-2008
 1 in 10 Americans age 12 and up, take an 
antidepressant.
 Up about 400 %, since 1994.
 Fewer than 1/3 have seen a MH professional in 
the past year.
Pratt, Brody & Gu, 2011.
What about Anti-psychotic 
Medications?
A world-wide study showed 
anti-psychotic meds are used 
nearly as often as drugs that 
control cholesterol::
Maggon (2009)

Anti-psychotics are widely 
used...
...But there is a catch:
Discontinuation rate by 18 months 
(due to side effects):
64% to 82%,
Depending on which anti-psychotic 
was taken.
Leiberman, et. al, 2005
New England Journal of Med.
Maybe the Congress will do 
something...
Drug industry spent over $22 
million lobbying congress in 
2007.
Proposals aimed at restricting 
advertising fell by the wayside.
AP, Feb 2008
 Pennsylvania hired 11 consultants to visit 
doctors to combat drug makers’ 
bombardment with sales reps and “ask your 
doctor” campaigns.
Drug industry trade group PhRMA said 
PA’s consultants are not held to same 
standards as drug company reps in their 
presentations.
AP, March 2008
Conclusions and Recommendations:
 Psychiatry has embraced non-science in order to 
protect its esteem and turf.
 Big Pharma has also thrown empiricism under the 
bus with its dishonesty regarding biological 
causation.
 Organized psychiatry and the pharmaceutical 
industry have become symbiotic: Bio-causation = 
drug treatment.
What’s a behavioral practioner to 
do?
Some suggestions follow.
Recommendation 1
Learn about the history of, and reinforcers for, 
adoption of the bio-causation model…
…Learn why pills trump skills.
Recommendation 2
Know about the tactics of the pharmaceutical 
industry:
– Payoffs to physicians.
– Downplay of dangerous drug side-effects.
– Overstatement of drug effectiveness.
– Canceled studies where preliminary results 
were not positive.
– Ghostwritten studies.
– Etc.
Recommendation 3
Develop a working knowledge of 
psychotropic medications.
Recommendation 4
Acknowledge that, at times, medications are 
effective.  Avoid a “drugs never helped 
anybody” approach.
Recommendation 5
Avoid sliding into the vortex of 
medicalization.  The world of of psychiatric 
hospitals, psychiatry and the insurance 
industry can pull you in.
Recommendation 6
Stay in touch with behavioral thinkers and 
thinking:
– Journals
– On-line discussions
– Associations
– Attend conferences
– Develop a behavioral support network.
Recommendation 7
For each client problem, have at the ready  a 
data-based description that shows how a 
behavioral method has worked with the 
same or a similar problem.
Recommendation 8
Avoid overuse of behavioral jargon, present 
company excepted.  “Speak so that the 
person sitting next to you on the bus would 
understand it.” (Paul chance, personal 
communication, date long forgotten.)
A corollary: Avoid overuse of layperson 
terms.
In summary:  Walk a fine line.
Recommendation 9
Quickly, and gently, refute common 
misunderstandings about behavioral 
methods and behavioral philosophy.
Some examples follow:
Myth: 
Behaviorists ignore genetic 
influences.
Reality:
Genes are important.  Our genetic structure 
enables us to change our behavior based on 
its consequences.
Myth:
Behaviorists discount or 
ignore thoughts and feelings.
Reality:
Thoughts and feelings are important, because 
we all have them.
They are behaviors, things we do, subject to 
the laws of behavior (reinforcement, etc.).
Myth:
Behaviorists favor punishment 
techniques.
Reality:
Positive reinforcement is the watchword of 
behaviorists.
Myth:
Behaviorists ignore the 
uniqueness of the individual.
Reality:
All individuals are unique because they have 
unique learning histories and genetic 
structures.
A final comment
 More than three decades ago B. F. Skinner 
wrote, “…genetic sources sometimes 
become a kind of dumping ground: any 
aspect of behavior which at the moment 
escapes analysis in terms of contingencies 
of reinforcement is likely to be assigned to 
genetic endowment…”  Skinner’s 
observation remains true today.
The End.
Thank you.
